- U.S. Food and Drug Administration (FDA) provides a clear regulatory pathway to Accelerated Approval for isaralgagene civaparvovec using data from ongoing Phase 1/2 STAAR study, avoiding requirement ...

Over the last several decades, the US Food and Drug Administration’s (FDA) accelerated approval program has largely been working as it was designed to, with about half the products using the pathway ...

For driven first-year RIT students like Lauren Reger and Palak Wadhwa, getting a jump on studying and conducting research, all while steadily moving on the path toward a graduate degree, was an ...

The Food and Drug Administration’s accelerated approval program aims to speed “approval of drugs that treat serious conditions, and fill an unmet medical need based on a surrogate endpoint” of overall ...

One hallmark of the FDA's accelerated approval pathway is the requirement that medicines prove their benefits in confirmatory trials. Now, new research shows that many cancer drugs approved under the ...

Rochester Institute of Technology’s College of Liberal Arts and University of Rochester’s Warner School of Education have established new 3+2 and 4+1 admissions agreements, providing RIT undergraduate ...

The accelerated approval was based on data from the phase 1/2 BRUIN trial that included a subset of 108 patients with CLL/SLL. The Food and Drug Administration (FDA) has granted accelerated approval ...

Accelerated approvals for cancer drugs is a good idea in theory. This US Food and Drug Administration (FDA) pathway allows promising new cancer agents to reach the market, and patients, sooner. But ...

The uncertainty of benefit at the time of accelerated approval may result in substantial spending on products that are ultimately proven ineffective. The heightened scrutiny on accelerated approvals ...